… SARS-CoV-2 proteins can … of SARS-CoV-2 from the whole viral particle to the individual
viral proteins and discuss their functions as well as their potential as targets for therapeutic …

… syndrome coronavirus 2 (SARS‐CoV‐2) by the coronavirus … caused by the 2019‐nCoV as
coronavirus disease (COVID‐19)… Therefore, we will review the current therapeutic and vaccine …

… into optimal usage of anti-SARS-CoV-2 therapies under development. In particular, it … -SARS-CoV-2
therapies to investigate the expected outcome under hypothetical drug therapies (or …

In this paper, the neurological aspects of COVID-19 are presented, which may be of
significance for physicians. Knowledge about the neurological symptoms of COVID-19 infection …

… SARS-CoV-2, similar to SARS-CoV, has characteristic transmembrane trimeric proteins that
facilitate the binding and fusion of the viral particle to the surface of the cell membrane of the …

… as influenza and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are a
constant … In this review, we discuss how infection with influenza or SARS-CoV-2 may induce …

… with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are insufficiently …
on SARS-CoV-2 pathogenesis and pathology to identify targets for therapeutic interventions …

… and infectivity by SARS-CoV. From this information, we also discuss potential therapeutic
opportunities including the use of soluble ACE2 proteins to intercept the SARS-CoV-2 so that …

… This article reports clinical experience from the SARS-CoV-2 … As with influenza, reverse
transcriptase-PCR for SARS-CoV-2 is … In China, SARS-CoV-2 has not shown a more severe …

… In this review, we focus on the current evidence of the relationship between SARS-CoV-2
and the gastrointestinal system; we outline the main implications on the management of …